Wird geladen...

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency

The design of modified oligonucleotides that combine in one molecule several therapeutically beneficial properties still poses a major challenge. Recently a new type of modified mesyl phosphoramidate (or µ-) oligonucleotide was described that demonstrates high affinity to RNA, exceptional nuclease r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proc Natl Acad Sci U S A
Hauptverfasser: Patutina, Olga A., Gaponova (Miroshnichenko), Svetlana K., Sen’kova, Aleksandra V., Savin, Innokenty A., Gladkikh, Daniil V., Burakova, Ekaterine A., Fokina, Alesya A., Maslov, Mikhail A., Shmendel’, Elena V., Wood, Mattew J. A., Vlassov, Valentin V., Altman, Sidney, Stetsenko, Dmitry A., Zenkova, Marina A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: National Academy of Sciences 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768764/
https://ncbi.nlm.nih.gov/pubmed/33288723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.2016158117
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!